Get the Stockscreener App
82.96
0.98%
-0.82
After Hours:
82.96
Lemaitre Vascular Inc stock is traded at $82.96, with a volume of 108.74K.
It is down -0.98% in the last 24 hours and up +0.01% over the past month.
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches and vessel closure systems.It has a single operating segment engaged in the development, manufacturing, and marketing of medical devices and implants, as well as the processing and cryopreservation of human tissues for implantation in patients.
See More
Previous Close:
$83.78
Open:
$84
24h Volume:
108.74K
Relative Volume:
0.68
Market Cap:
$1.88B
Revenue:
$213.03M
Net Income/Loss:
$41.32M
P/E Ratio:
45.33
EPS:
1.83
Net Cash Flow:
$33.49M
1W Performance:
-1.83%
1M Performance:
+0.01%
6M Performance:
+0.47%
1Y Performance:
-10.64%
1-Day Range:
$82.64
$86.00
1-Week Range:
$82.64
$86.00
52-Week Range:
$71.42
$105.55
Lemaitre Vascular Inc Stock (LMAT) Company Profile
Name
Lemaitre Vascular Inc
Sector
Industry
Phone
781-221-2266
Address
63 SECOND AVENUE, BURLINGTON, MA
Compare LMAT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LMAT
Lemaitre Vascular Inc
|
82.96 | 1.90B | 213.03M | 41.32M | 33.49M | 1.83 |
|
ISRG
Intuitive Surgical Inc
|
575.40 | 204.83B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
195.16 | 55.94B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
80.35 | 39.48B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
242.85 | 35.73B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
42.00 | 34.74B | 27.43B | 1.27B | 1.01B | 1.5829 |
Lemaitre Vascular Inc Stock (LMAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-06-25 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Feb-28-25 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Feb-28-25 | Downgrade | Oppenheimer | Outperform → Perform |
| Feb-13-25 | Initiated | Wells Fargo | Equal Weight |
| Oct-15-24 | Initiated | Cantor Fitzgerald | Neutral |
| Aug-02-24 | Resumed | Lake Street | Buy |
| May-31-24 | Resumed | ROTH MKM | Buy |
| Apr-26-24 | Upgrade | Stifel | Hold → Buy |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Sector Weight |
| Oct-23-23 | Initiated | JMP Securities | Mkt Outperform |
| Sep-06-23 | Initiated | Oppenheimer | Outperform |
| Aug-03-23 | Downgrade | Jefferies | Buy → Hold |
| May-03-23 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Oct-28-22 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Sep-16-21 | Initiated | Jefferies | Buy |
| Feb-12-21 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Mar-16-20 | Upgrade | Sidoti | Neutral → Buy |
| Oct-24-19 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
| Oct-24-19 | Upgrade | Lake Street | Hold → Buy |
| Oct-14-19 | Upgrade | First Analysis Sec | Outperform → Strong Buy |
| Jul-25-19 | Reiterated | Barrington Research | Outperform |
| Jul-25-19 | Upgrade | First Analysis Sec | Neutral → Outperform |
| Oct-08-18 | Upgrade | Barrington Research | Mkt Perform → Outperform |
| Oct-08-18 | Upgrade | ROTH Capital | Neutral → Buy |
| Jun-08-18 | Resumed | ROTH Capital | Buy |
| Apr-26-18 | Downgrade | Stifel | Buy → Hold |
| Apr-26-18 | Upgrade | The Benchmark Company | Hold → Buy |
| Oct-27-17 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| Oct-27-17 | Downgrade | The Benchmark Company | Buy → Hold |
| Jul-10-17 | Downgrade | Canaccord Genuity | Buy → Hold |
| Jul-10-17 | Downgrade | The Benchmark Company | Buy → Hold |
| Mar-21-17 | Initiated | First Analysis Sec | Overweight |
| Feb-22-17 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| Sep-22-16 | Downgrade | Sidoti | Buy → Neutral |
| Jul-28-16 | Reiterated | Barrington Research | Outperform |
| Feb-25-16 | Reiterated | Barrington Research | Outperform |
View All
Lemaitre Vascular Inc Stock (LMAT) Latest News
Will LeMaitre Vascular Inc. stock beat EPS estimatesReal-Time Stock Alerts & Low Cost Trading Plans - bollywoodhelpline.com
Harbor Capital Advisors Inc. Trims Stake in LeMaitre Vascular, Inc. $LMAT - Defense World
Hedge Fund Bets: What analyst consensus implies for LeMaitre Vascular Inc LHU stockEarnings Growth Summary & Stock Portfolio Risk Management - moha.gov.vn
Rice Hall James & Associates LLC Sells 35,684 Shares of LeMaitre Vascular, Inc. $LMAT - MarketBeat
Reflecting On Surgical Equipment & ConsumablesSpecialty Stocks’ Q3 Earnings: LeMaitre (NASDAQ:LMAT) - Yahoo Finance
Comparing LeMaitre Vascular (NASDAQ:LMAT) & Sunny Optical Technology (Group) (OTCMKTS:SNPTF) - Defense World
(LMAT) Risk Channels and Responsive Allocation - Stock Traders Daily
LeMaitre Vascular (NASDAQ:LMAT) Hasn't Managed To Accelerate Its Returns - Yahoo Finance
Is LeMaitre Vascular Inc. (LHU) stock prepared for digital transition2025 Market Outlook & Weekly Breakout Watchlists - Улправда
Congress Asset Management Co. Has $60.58 Million Stake in LeMaitre Vascular, Inc. $LMAT - MarketBeat
What risks investors should watch in LeMaitre Vascular Inc. stockJuly 2025 Gainers & Long Hold Capital Preservation Plans - Улправда
Support Test: What risks investors should watch in LeMaitre Vascular Inc. stockDividend Hike & Free Technical Confirmation Trade Alerts - Улправда
Why LeMaitre Vascular Inc. stock could see breakout soonJuly 2025 News Drivers & Fast Moving Stock Watchlists - Улправда
Will LeMaitre Vascular Inc. stock benefit from automationEntry Point & AI Enhanced Trading Alerts - Улправда
CEO Change: Will LeMaitre Vascular Inc. stock beat EPS estimatesCEO Change & Risk Controlled Daily Trade Plans - Улправда
Is LeMaitre Vascular Inc. stock gaining market shareJuly 2025 Institutional & Pattern Based Trade Signal System - DonanımHaber
Why retail investors favor LeMaitre Vascular Inc. stockTrade Ideas & Free Expert Verified Stock Movement Alerts - DonanımHaber
Why LeMaitre Vascular Inc. stock appeals to dividend seekersJuly 2025 Big Picture & Expert Verified Stock Movement Alerts - Улправда
Is LeMaitre Vascular Inc. stock a top pick in earnings seasonPortfolio Value Summary & Verified Entry Point Detection - DonanımHaber
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Is LeMaitre Vascular Inc. stock attractive for retirement portfoliosJuly 2025 Movers & Reliable Intraday Trade Alerts - Улправда
Will LeMaitre Vascular Inc. (LHU) stock outperform energy sector in 2025July 2025 Retail & Trade Opportunity Analysis Reports - Улправда
Why LeMaitre Vascular Inc. stock is favored by pension fundsJuly 2025 Rallies & Precise Buy Zone Identification - Улправда
Patterns Watch: What analyst consensus implies for LeMaitre Vascular Inc LHU stockWeekly Gains Report & Safe Capital Investment Plans - moha.gov.vn
Portfolio Recap: Can LeMaitre Vascular Inc stock reach 100 price targetJuly 2025 Snapshot & Advanced Swing Trade Entry Alerts - moha.gov.vn
LeMaitre Vascular Inc Stock Analysis and ForecastGrowth vs. Value Investing & Free Tools to Find Winning Stocks - earlytimes.in
Is Jinhui Shipping and Transportation Limited J4O a good long term investmentSupport and Resistance Levels & Free High Velocity Capital Growth - earlytimes.in
Pres Roberts Disposes 840 Of LeMaitre Vascular Inc [LMAT] - TradingView — Track All Markets
LeMaitre Vascular (LMAT) insider details option exercises and trust transfer - Stock Titan
[Form 4] LEMAITRE VASCULAR INC Insider Trading Activity - Stock Titan
LeMaitre Vascular (LMAT) insider reports RSU, PSU vesting and share withholding - Stock Titan
LeMaitre Vascular (LMAT) director adds shares via dividend rights vesting - Stock Titan
LeMaitre Vascular (LMAT) director gains shares from dividend rights - Stock Titan
LeMaitre Vascular (LMAT) director receives shares from 12/12/2022 equity awards - Stock Titan
LeMaitre Vascular Inc. (LMAT) director details dividend right share conversions - Stock Titan
LeMaitre Vascular (LMAT) director gains shares via dividend rights - Stock Titan
LeMaitre Vascular, Inc. $LMAT Shares Sold by AWM Investment Company Inc. - Defense World
Wells Fargo Sticks to Their Hold Rating for Lemaitre Vascular (LMAT) - The Globe and Mail
LeMaitre Vascular (NASDAQ: LMAT) awards RSUs and options to operations VP - Stock Titan
LeMaitre Vascular (LMAT) insider reports 2025 RSU and option equity grants - Stock Titan
LeMaitre Vascular Inc (LMAT) director reports RSU and option awards - Stock Titan
LeMaitre Vascular (NASDAQ: LMAT) director reports new equity award grants - Stock Titan
(LMAT) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
American Century Companies Inc. Has $2.82 Million Holdings in LeMaitre Vascular, Inc. $LMAT - MarketBeat
First Trust Advisors LP Increases Stock Position in LeMaitre Vascular, Inc. $LMAT - Defense World
Dir O'Connor Acquires 1 Of LeMaitre Vascular Inc [LMAT] - TradingView
LeMaitre Vascular, Inc. $LMAT Shares Sold by JPMorgan Chase & Co. - MarketBeat
LeMaitre Vascular (LMAT) details insider stock and dividend rights moves - Stock Titan
LeMaitre Vascular (NASDAQ:LMAT) Cut to Hold at Wall Street Zen - MarketBeat
Quantbot Technologies LP Increases Stock Holdings in LeMaitre Vascular, Inc. $LMAT - MarketBeat
Lemaitre Vascular Inc Stock (LMAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.33%
0.01%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):